Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trialMehreen S. Datoo, Nsajigwa Misidai, Alassane Dicko et al.|The Lancet|2024Cited by 345
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trialAlassane Dicko, Teun Bousema, Sékou F. Traorè et al.|The Lancet Infectious Diseases|2018Cited by 126
Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trialWilliam J. Stone, Alassane Dicko, Almahamoudou Mahamar et al.|The Lancet Microbe|2021Cited by 38
Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trialsHalimatou Diawara, Sara A. Healy, Agnes Mwakingwe-Omari et al.|The Lancet Infectious Diseases|2024Cited by 31
A Phase III Randomised Controlled Trial Evaluating the Malaria Vaccine Candidate R21/Matrix-M™ in African ChildrenMehreen Datoo, Adrian V. S. Hill, Alassane Dicko et al.|SSRN Electronic Journal|2023Cited by 29